Download Files:
Adefovir dipivoxil
$55 – $308
Products Details
Product Description
– Adefovir dipivoxil, an adenosine analogue, is an oral proagent of the nucleoside reverse transcriptase inhibitor Adefovir. Adefovir dipivoxil inhibits both the wild type and HBV Lamivudine-resistant strains[1][2]. Adefovir dipivoxil shows anti-orthopoxvirus activity.
Web ID
– HY-B0255
Storage Temperature
– -20°C, 3 years; 4°C, 2 years (Powder)
Shipping
– Room Temperature
Applications
– COVID-19-anti-virus
Molecular Formula
– C20H32N5O8P
References
– [1]Mark N Prichard, et al. Orthopoxvirus targets for the development of antiviral therapies. Curr Drug Targets Infect Disord. 2005 Mar;5(1):17-28. |[2]Noble S, et al. Adefovir dipivoxil. Drugs. 1999;58(3):479-489.|[3]Buti M, et al. Adefovir dipivoxil. Drugs Today (Barc). 2003;39(2):127-135.
CAS Number
– 142340-99-6
Molecular Weight
– 501.47
Compound Purity
– 99.99
SMILES
– NC1=C2N=CN(CCOCP(OCOC(C(C)(C)C)=O)(OCOC(C(C)(C)C)=O)=O)C2=NC=N1
Clinical Information
– Launched
Research Area
– Infection; Cancer
Solubility
– DMSO : ≥ 100 mg/mL|H2O : 0.67 mg/mL (ultrasonic)
Target
– Endogenous Metabolite;HBV;Orthopoxvirus;Reverse Transcriptase
Pathway
– Anti-infection;Metabolic Enzyme/Protease
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
